Back to top
more

Patterson Companies (PDCO)

(Delayed Data from NSDQ)

$20.27 USD

20.27
689,626

-0.01 (-0.05%)

Updated Oct 8, 2024 03:59 PM ET

After-Market: $20.27 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value F Growth B Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 30% (176 out of 252)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Hologic (HOLX) Rides on Robust Preliminary Q1 Organic Sales

by Zacks Equity Research

The uptick in Hologic's (HOLX) Diagnostics sales is likely the result of increased demand for COVID-19 testing.

Hologic (HOLX) to Expand in Oncology With Biotheranostics Buyout

by Zacks Equity Research

Hologic (HOLX) aims to strengthen its Diagnostics business by foraying into the oncology adjacency space via the acquisition of Biotheranostics.

Is Patterson Companies (PDCO) Outperforming Other Medical Stocks This Year?

by Zacks Equity Research

Is (PDCO) Outperforming Other Medical Stocks This Year?

Cardinal Health (CAH) Unveils New Logistics Management Tool

by Zacks Equity Research

Cardinal Health's (CAH) company, OptiFreight Logistics, launched TotalVue Analytics to help healthcare supply chain leaders to drive cost savings.

DENTSPLY (XRAY) Acquires Byte to Boost Clear Aligner Business

by Zacks Equity Research

DENTSPLY (XRAY) acquires Byte to strengthen presence in the lucrative clear aligner space.

Here's Why You Should Retain Cardinal Health (CAH) Stock Now

by Zacks Equity Research

Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment, diversified product portfolio and buyouts.

Here's Why You Should Retain Integer Holdings (ITGR) Stock Now

by Zacks Equity Research

Integer Holdings (ITGR) continues to gain traction from portfolio management. However, intense competition is a woe.

OPKO Health's (OPK) BioReference Starts Fan Testing Program

by Zacks Equity Research

OPKO Health's (OPK) BioReference commences mandatory, large-scale COVID-19 testing programs for fans for AFC Division Wild Card playoff game.

Patterson Cos. (PDCO) Down 7.4% Since Last Earnings Report: Can It Rebound?

by Zacks Equity Research

Patterson Cos. (PDCO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Here's Why You Should Hold on to Cerner (CERN) Stock Now

by Zacks Equity Research

Cerner (CERN) continues to gain from solid prospects in EHR and strategic deals. However, intense competition remains a woe.

    Here's Why You Should Hold on to Intuitive Surgical (ISRG) Now

    by Zacks Equity Research

    Intuitive Surgical (ISRG) continues to gain traction from improving adoption of da Vinci Surgical System. But weak operational performance is a woe.

    Nevro's (NVRO) FDA Submission to Treat Patients With PDN

    by Zacks Equity Research

    Nevro's (NVRO) submission of a pre-market approval supplement to the FDA to seek approval for its Senza System can help in the treatment of chronic pain associated with PDN.

    HMS Holdings (HMSY) to be Acquired by Gainwell for $3.4B

    by Zacks Equity Research

    HMS Holdings (HMSY) entered into an agreement to be acquired by Gainwell in an all-cash transaction deal worth about $3.4 billion.

    Here's Why You Should Retain Cooper Companies (COO) Stock

    by Zacks Equity Research

    Cooper Companies (COO) continues to benefit from solid CVI and CSI product portfolios.

    Intersect ENT (XENT) Banks on SINUVA Sales Amid COVID-19 Woes

    by Zacks Equity Research

    Intersect ENT's (XENT) potential in chronic sinusitis market and progress in SINUVA and PROPEL product lines are encouraging.

    Masimo's (MASI) Telehealth Solution Helps in COVID-19 Crisis

    by Zacks Equity Research

    Masimo (MASI) is lending support to Renown Health through Masimo SafetyNet in order to manage the COVID-19 surge.

    Here's Why You Should Retain AmerisourceBergen (ABC) Now

    by Zacks Equity Research

    AmerisourceBergen (ABC) continues to gain traction from robust pharmaceutical segment and new product launches.

    Abiomed's (ABMD) ECMO Technology Completes Successful Treatment

    by Zacks Equity Research

    Abiomed (ABMD) successfully treats first two patients in the world with the help of its Breethe OXY-1 System.

    Here's Why You Should Retain Stryker Stock Right Now

    by Zacks Equity Research

    Stryker (SYK) continues to benefit from strength in its robotic-arm assisted surgery platform - Mako and broad product portfolio. However, pricing pressure raises concern.

    NextGen (NXGN) Solutions Support COVID-19 Vaccine Distribution

    by Zacks Equity Research

    NextGen (NXGN) lends a hand to the nationwide rollout of COVID-19 vaccines through its robust EHR platform and integrated solutions.

    Trina Mukherjee headshot

    Grab 3 Dental Stocks More Than Doubling Industry Gains for 2021

    by Trina Mukherjee

    Buy these three top dental stocks that have shown sharp recovery despite market volatility due to the pandemic, and have the potential to continue their bull run in 2021.

    PDCO or ALGN: Which Is the Better Value Stock Right Now?

    by Zacks Equity Research

    PDCO vs. ALGN: Which Stock Is the Better Value Option?

    Is Patterson Companies (PDCO) Stock Outpacing Its Medical Peers This Year?

    by Zacks Equity Research

    Is (PDCO) Outperforming Other Medical Stocks This Year?

    Should Value Investors Pick Patterson Companies (PDCO) Stock?

    by Zacks Equity Research

    Let's see if Patterson Companies (PDCO) stock is a good choice for value-oriented investors right now from multiple angles.

    Earnings Estimates Rising for Patterson Cos. (PDCO): Will It Gain?

    by Zacks Equity Research

    Patterson Cos. (PDCO) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.